Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs 
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic 
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears 
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand 
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth 
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
Bank of America's $72.5M Epstein Settlement: What You Need to Know 
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 
NEW YORK, Jan. 09, 2017 -- Progyny, a leading reproductive health technology and services company, today announced the appointment of former WebMD CFO, Peter Anevski, as its Chief Financial Officer and Chief Operating Officer. He joins newly appointed Chief Executive Officer, David Schlanger, and President of Health Services, Karin Ajmani, on Progyny’s management team.
“I’m delighted to become a part of Progyny and resume my longstanding working relationship with CEO, David Schlanger. It’s an exciting time to be at the company as it charts the next phase of growth in developing unique science-based and data-driven reproductive technology and in penetrating the employer market for fertility benefits,” said Anevski.
Commenting on Anevski’s appointment, Schlanger commented: “Pete brings over 17 years of experience in the healthcare industry at WebMD where he and I worked together to deliver record revenues and profits and substantial share price appreciation during the more than three years that we led the company. Progyny is now in a position where it needs the financial and operations skills of someone like Pete. He will be a critical member of the management team that will take Progyny forward to capitalize on the significant opportunity in the global fertility services market.”
About Peter Anevski
Pete joined WebMD in 1999 and served as senior management in a number of finance and operations roles, becoming the company's CFO in 2013. He played an integral role in WebMD’s growth in revenue and profitability through implementation of changes in pricing and market positioning, programmatic strategy and execution and other finance and operating disciplines that led to the company's improved financial performance. Prior to joining WebMD, Pete was in corporate accounting at Toys "R" Us and a CPA with Wiss &Co, LLP.
ABOUT PROGYNY
Progyny is a leading reproductive health technology and services company that combines data, science and technology to provide the first end-to-end, proactive fertility solution for self-insured employers to offer as a benefit to employees.
Progyny’s SMART Cycle™ plan design improves outcomes, shortens time to pregnancy and reduces total fertility-related costs. Progyny is privately held and is headquartered in New York, NY, with operations in San Francisco, CA. Please visit www.progyny.com.
Media Contact: Selena Yang [email protected]
